Previously treated amyloid light-chain (AL) amyloidosis

Clinical trials for Previously treated amyloid light-chain (AL) amyloidosis explained in plain language.

Never miss a new study

Get alerted when new Previously treated amyloid light-chain (AL) amyloidosis trials appear

Sign up with your email to follow new studies for Previously treated amyloid light-chain (AL) amyloidosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New Triple-Action antibody targets Hard-to-Treat blood cancers

Disease control Recruiting now

This early-phase study tests an experimental drug called JNJ-79635322, a trispecific antibody designed to attack cancer cells in people with relapsed or refractory multiple myeloma or AL amyloidosis. About 180 participants will receive the drug to find a safe dose and check for s…

Matched conditions: PREVIOUSLY TREATED AMYLOID LIGHT-CHAIN (AL) AMYLOIDOSIS

Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control

Last updated Aug 30, 2026 00:00 UTC

Previously treated amyloid light-chain (AL) amyloidosis

Get alerted when new Previously treated amyloid light-chain (AL) amyloidosis trials appear

New Triple-Action antibody targets Hard-to-Treat blood cancers